Spectroscopy Evidence of Diffuse Brain Abnormalities in Patients with Epileptogenic Foci

References

1. ↵
   Duncan JS. Brain imaging in idiopathic generalized epilepsies. Epilepsia 2005;46 Suppl 9:108–11
2. ↵
   Helms G, Ciumas C, Kyaga S, et al. Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalized epilepsy. J Neurol Neurosurg Psychiatry 2006;77:489–94

   Abstract/FREE Full Text
3. ↵
   Meencke H-J, Veith G. Migration disturbances in epilepsy In: Engel Jr J, Wasterlain C, Cavalheiro EA, eds. Molecular Neurobiology of Epilepsy, Series Epilepsy Research Supplements, 9. Elsevier;1992
4. ↵
   Kuzniecky R. Clinical applications of MR spectroscopy in epilepsy. Neuroimaging Clin N Am 2004;14:507–16

   CrossRefPubMed
5. ↵
   Hammen T, Stefan H, Pauli E, et al. 1H-MR spectroscopy: a promising method in distinguishing subgroups in temporal lobe epilepsy? J Neurol Sci 2003;215:21–25

   CrossRefPubMed
6. ↵
   Hammen T, Kerling F, Schwartz M, et al. Identifying the affected hemisphere by (1)H-MR spectroscopy in patients with temporal lobe epilepsy and no pathological findings in high resolution MRI. Eur J Neurol 2006;13:482–90

   CrossRefPubMed
7. ↵
   Lantz G, Seeck M, Lazeyras F. Extent of preoperative abnormalities and focus lateralization predict postoperative normalization of contralateral 1H-magnetic resonance spectroscopy metabolite levels in patients with temporal lobe epilepsy. AJNR Am J Neuroradiol 2006;27:1766–69

   Abstract/FREE Full Text
8. ↵
   Burneo JG, Knowlton RC, Faught E, et al. Chronic temporal lobe epilepsy: spatial extent and degree of metabolic dysfunction studied with magnetic resonance spectroscopy (MRS). Epilepsy Res 2004;62:119–24

   CrossRefPubMed
9. ↵
   Serles W, Li LM, Antel SB, et al. Time course of postoperative recovery of N-acetly-aspartate in temporal lobe epilepsy. Epilepsia 2001;42:190–97

   CrossRefPubMedWeb of Science
10. ↵
    Mueller SG, Laxer KD, Cashdollar N, et al. Spectroscopic evidence of hippocampal abnormalities in neocortical epilepsy. Eur J Neurol 2006;13:256–60

    CrossRefPubMed
11. ↵
    Wellard RM, Briellmann RS, Wilson JC, et al. Longitudinal study of MRS metabolites in Rasmussen encephalitis. Brain 2004;127:1302–12

    Abstract/FREE Full Text
12. ↵
    Mueller SG, Laxer KD, Barakos JA, et al. Metabolic characteristics of cortical malformations causing epilepsy. J Neurol 2005;252:1082–92

    CrossRefPubMed
13. ↵
    Eriksson SH, Rugg-Gunn FJ, Symms MR, et al. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain 2001;124:617–26

    Abstract/FREE Full Text
14. ↵
    Spencer DC, Szumowski J, Kraemer DF, et al. Temporal lobe magnetic resonance spectroscopic imaging following selective amygdalohippocampectomy for treatment-resistant epilepsy. Acta Neurol Scand 2005;112:6–12

    CrossRefPubMed
15. ↵
    Vuori K, Kankaanranta L, Häkkinen AM, et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 2004;230:703–08

    PubMed